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Summary We propose a general model for neoplastic development which postulates that the loss of methyl
groups from 5-methylcytosines (5-mC) involved in the control of gene expression may initiate neoplastic
transformation and give rise to the aberrant phenotype of the transformed cell. Interference with normal
patterns of methylation can be envisioned to occur by a number of mechanisms: as a result of carcinogen-
induced G:C-CA:T transition leading to a loss of potentially methylatable cytosines; by mutations or
chromosome rearrangement which disrupt the integrity of active DNA methylase genes; by separating
methylated repressor regions of the genome from the genes they control; by direct interference with DNA
methylation, as proposed for ethionine and 5-azacytidine; by spontaneous deamination of 5-mC to thymine,
leading to accumulation of 5-mC:G-_T:A transitions; by virus-induced perturbations in host cell methylation
patterns; and by activation of DNA demethylases.
Perhaps the most ubiquitous aspect of tumours and
the neoplastic cells of which they are composed is
their loss of the ability to control cellular functions
in a normal way. During the development of the
malignant state, the neoplastic cell becomes
increasingly refractory to both the internal and
external stimulae which integrate its normal
counterparts into functional tissues and organ
systems. This lack of integration is associated with
alterations in the expression of a host of gene
products, including, for example, the ectopic
biosynthesis of hormones (Rees, 1975; Imura,
1980), various nuclear modifications (Rovera, 1975;
Sarma et al., 1975), changes in enzyme and isozyme
patterns (Weinhouse, 1970, 1980, Weinhouse et al.,
1972; Ibsen, 1977; Ghosh et al., 1978; Foti et al.,
1977; Greengard & Herzfeld, 1977; Shapira et al.,
1963), appearance of foetal antigens (Gold, 1971)
and cell surface modifications (Robin & Nicholson,
1975; Mora, 1974). It is thus clear that a powerful
interference with the normal machinery of gene
expression accompanies the transformed state. Such
aberrant gene expression may yield to the
transformed cell the required release from
physiological control that defines neoplasia. Altered
metabolism resulting from the appearance of
isozymic forms may be the key both to such loss of
host control and to the unbridled growth that are
Correspondence: J.W. Nyce, Fels Research Institute,
Temple University School of Medicine, 3420 North Broad
Street, Philadelphia, PA 19140.
Received 15 June 1983; accepted 14 July 1983.
characteristic of rapidly growing tumours
(Weinhouse, 1974).
As yet, altered gene expression has not been
linked with the various processes known to produce
tumours. Presented here is a model which proposes
a basis for such a link, and which additionally
provides a high degree of relevance to available
data. The model is based upon a possible relation-
ship between normal physiological methylation
of DNA and chemically-induced alkylation of
DNA, viz., that carcinogen-induced alkylation
leads to disappearance of sites of enzymatic
methylation of DNA. Such hypomethylation
would cause the expression of genes otherwise
repressed, for example, those for isozymes, foetal
antigens, ectopic hormones, etc.
Enzymatic methylation in gene expression
There is increasing evidence that the enzymatic
methylation of DNA at the 5-position of cytosine
exerts some influence over the expression of
eukaryotic genes, as suggested by Holliday & Pugh
(1975), Riggs (1975) and Scarano (1971). McGhee
& Ginder (1979) have shown that in adult
reticulocytes and erythrocytes which are expressing
or have expressed the adult P-globin gene, CCGG
sites near the ends of the gene sequence are
unmethylated, whereas in oviduct, brain and
embryonic red blood cells, which do not express
this gene, such sites are at least partially
methylated. Christman et al. (1977) found that
DNA isolated from Friend erythroleukaemic cells
induced to produce globin mRNA is
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hypomethylated when compared to DNA from
uninduced cells. Mandel & Chambon (1979)
demonstrated the existence of a class ofmethylation
sites (mvar) within and around the conalbumin,
ovomucoid, and ,B-globin genes, the variable
methylation of which correlated with trans-
criptional activity. When a gene region is in an
active chromatin conformation, as measured by
DNase I sensitivity (Kuo et al., 1979), there is
extensive hypomethylation at many of these mvar
sites. Sites of residual methylation near transcribed
genes, as well as undermethylated sites near genes
not being transcribed, were absent in DNase I-
sensitive active chromatin. Based on these results,
these authors suggest that in all tissues there is a
certain possibility that an mvar site is present in the
unmethylated state; thus only undermethylation at
a substantial number of mvar sites of a given
genomic region would be significantly correlated
with the active state of chromatin. This and other
information (for review see Doerfler, 1981) indicate
that methylation at specific cytosine residues in
DNA at specific times may be closely associated
with the regulation of gene expression.
Furthermore, the demonstration of specific
unmethylated CG doublets in mammalian DNA by
Browne et al. (1978) and the stringent conservation
of the pattern of methylation throughout vertebrate
evolution (Browne & Burdon, 1977) imply rigorous
control of the DNA methylation system.
It has been suggested that 5-methylcytosine
(5-mG) may provide signals for regulatory protein
binding (Yuan & Meselson, 1970). Indeed, it is well
established that the Escherichia coli K restriction
and modification enzyme has a strong affinity for
an unmethylated site but no detectable affinity for
a methylated site. Sista et al. (1979) have shown
that the 5-methyl group of thymine is the only
important functional group recognized by the lac
repressor at position 13 of the lac operator.
Replacing thymine with cytosine resulted in a 7-8
fold decrease in lac repressor binding, whereas
5-mC bound repressor at least as tightly as the wild
type sequence. Thus methylation is already known
to affect the binding of sequence-specific proteins
to prokaryotic DNA. It seems a reasonable
working hypothesis that the insertion of a
hydrophobic methyl group into the major groove of
DNA, as occurs with the methylation of cytosine,
might affect protein binding in eukaryotic systems
as well.
Chemical alkylation ofDNA
Evidence has accumulated that non-enzymatic
alkylation of DNA may also be biologically
relevant. The site of alkylation of a nucleic acid, in
vivo or in vitro, is greatly dependent upon the type
of alkylating agent (Jensen, 1978; Singer et al.,
1978). In general, alkylating agents with low
mutagenicity or carcinogenicity, such as dimethyl
sulfate, are weak electrophiles and tend to attack
primarily ring nitrogens. Agents that produce more
reactive electrophilic species, such as N-nitroso and
related compounds (Magee, 1977a, 1978), show an
increasing ability to alkylate oxygen, reacting with
all ring oxygens as well as phosphodiesters (Jensen
& Reed, 1978; Singer, 1977, 1979). These
compounds are very potent carcinogens, and many
show an intriguing organ specificity (Druckrey,
1967).
Although N-nitroso and related compounds
produce lesions at a variety of sites on DNA,
alkylation at the 06-position of guanine is thought
to be responsible for the subsequent induction of
tumours by these agents (Magee, 1976, 1979; Pegg
& Nicoll, 1976; Lawley, 1980; Frei et al., 1978).
The persistence of 06-alkylguanine in DNA of
various rat and mouse tissues (Goth & Rajewsky,
1974; Kleihues & Margison, 1974; Margison et al.,
1976) correlates with the organ specificity of these
compounds, especially when the rate of cell
replication of the examined tissue is considered.
The persistence of other lesions, such as those
produced at the 7-position of guanine, the major
site of alkylation, fails to predict which organs will
serve as specific targets for tumorigeiesis.
Goth & Rajewsky (1974) compared the
persistence of O6-ethylguanine in brain and liver of
10 day old rats treated with a single dose of
N-ethyl-N-nitrosourea under conditions known to
be selectively tumorigenic for brain but not liver.
Molar fractions of O6-ethylguanine, 7-ethylguanine,
and 3-ethylguanine at one hour after injection were
very similar in each tissue. The rate of removal of
06-ethylguanine over a 240h period, however, was
much slower in brain than in liver. Nicoll et al.
(1975) have shown that after a single large dose of
dimethylnitrosamine, 06-methylguanine is much
longer lived in the kidney where tumours develop
than in the liver, where they do not; and Kleihues
& Margison (1974) found that in rats treated with
methylnitrosourea, a potent neurogenic carcinogen
which occasionally also produces tumours in the
kidney but never in the liver, 06-methylguanine is
removed from DNA least rapidly in the brain, most
rapidly in the liver, and at an intermediate rate in
the kidney. The resistance of the liver and the
susceptibility of the brain and kidney to
tumorigenesis induced by a single dose of either
ethylnitrosourea, dimethylnitrosamine or methyl-
nitrosourea therefore appears to be related to the
ability of these tissues to remove 06-alkylguanine
lesions from their respective DNAs.5-mC DEPLETION DURING TUMOUR DEVELOPMENT 465
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Figure 1 Diagrammatic representation of guanine alkylation-induced loss of methylatable cytosines following
2 or 3 rounds of replication. Original strands are shown in bold type, new strands in light type.
Do the biological effects of enzymatic and chemical
alkylation intersect?
Based on the suggestion of Loveless (1969) that
06-alkylation of guanine could lead to mispairing
during DNA replication, Gerchman & Ludlum
(1973) have shown in their in vitro transcription
system that 06-methylguanine mispairs with
thymine in place of cytosine. Assuming that a
similar mispairing event can occur in vivo, we
suggest that the critical result of G:C06_
MeG:C-O6-MeG:T-A:T transitions during
DNA replication in N-nitrosamine-induced
carcinogenesis is the loss of cytosine residues which
may otherwise be potential sites of enzymatic
methylation at the C-5 position (Figure 1). Such
depletion of sites of enzymatic methylation may
interfere with the otherwise rigidly fixed pattern of
gene expression characteristic of fully differentiated
cells. The aberrant gene expression and consequent
unorchestrated attempt at differentiation that may
result in a hypomethylated cell might then give rise,
in both morphological and biological terms, to the
transformed state. Transition mutations or other
events (see below) leading to DNA
hypomethylation are thus seen as capable of
initiating the neoplastic phenotype by setting in
motion programmes of transcription that disrupt
the state of cellular differentiation.
Evidence in support ofthe model
Bryngelsson & Pero (1980) have presented evidence
that the adenosine to guanine ratio of 1.272 in
normal rat DNAs is significantly lower than that of
1.342 in tumours induced by a variety of agents,
including 7,12-dimethylbenz(a)-anthracene, 3-
methylcholanthrene, 3,4-benzo(a)pyrene, and 1,2-
dimethylhydrazine. Their data indicate that -1%
of rat tumour DNA or one in every 50 base pairs
has an altered purine or pyrimidine residue
compared to normal rat DNAs. Kasten et al.
(1982) found that, following DNA damage induced
in human diploid fibroblasts by ultraviolet
irradiation, N-methyl-N-nitrosourea, or N-acetoxy-
2-acetylaminofluorene, repaired patches of DNA
remained permanently undermethylated. According
to Lapeyre & Becker (1979), rats treated with
acetylaminofluorene, DNA from resulting
premalignant hepatic nodules was undermethylated
by 20%. Primary hepatocellular carcinomas found
in these animals were undermethylated by
45% and diethylnitrosamine-induced hepatocellular
carcinomas were undermethylated by 32.5%.
Further evidence in favour of the model comes
from work with the amino acid analogue and
hepatic carcinogen, L-ethionine. Ethionine is only
one carbon atom larger than the essential amino
acid methionine, is metabolized via the same
pathways as methionine (Stekol, 1963), and yet
gives rise to numerous hepatocarcinomas when
included in the diet (Farber, 1963). Although
significant transfer of the ethyl group of ethionine
to RNA occurs (Farber & Magee, 1960; Craddock,
1969), very little reaction with DNA is observed
(Swann et al., 1971; Ortwerth & Novelli, 1969).
Significantly, Farber (1973) has pointed out that
ethionine may be the exception to the rule that
hepatocarcinogens damage DNA in a way
detectable on alkaline sucrose gradients. It is
impossible to rule out a role for direct ethylation of
DNA in the mechanism of action of ethionine-
induced carcinogenesis. However, levels of
ethylation (Swann et al., 1971; Ortwerth & Novelli,
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1969; Grilli et al., 1974), and of repair of induced
DNA single strand breaks (Craddock & Henderson,
1978; Farber, 1973), approach insignificance when
compared to levels induced by other hepatocar-
cinogens. Furthermore, only 7-ethylguanine (Swann
et al., 1971) and not O6-ethylguanine or other
miscoding and presumably oncogenic lesions, have
been observed after ethionine treatment. This also
contrasts with what is observed after treatment with
other alkylating hepatocarcinogens, where 06_
alkylguanine occurs to a very significant extent
(Magee et al., 1976; Margison et al., 1976; Nicoll et
al., 1977). We would like to offer, within the
context of the model we are developing here, a
possible mechanism of action for ethionine
carcinogenesis which is an alternative to the direct
DNA ethylation concept.
Smith & Salmon (1965) demonstrated that
ethionine administration leads to the accumulation
of S-adenosylethionine (SAE); and Cox & Irving
(1977) found that SAE, as a metabolic analogue of
S-adenosylmethionine (SAM), competitively inhibits
DNA methylase in vivo, resulting in methyl-
deficient DNA. Such inhibition of methylation by
SAE is reversible upon replenishment of SAM
pools, and the toxic and carcinogenic effects of
ethionine can be reversed by the simultaneous
administration of methionine (Farber & Ichinose,
1958; Brada et al., 1976). Methionine may thus
overcome the carcinogenic effects of ethionine by
maintaining the ratio of SAM to SAE at a
sufficiently high level to allow normal methylation
ofcytosine.
Since tRNA is ethylated by ethionine in vivo, it
has been suggested that tRNA is the target for
ethionine carcinogenesis (Borek & Kerr, 1971;
Srinivasan & Borek, 1964). There are very little
data to support this suggestion however, since there
is increasing evidence that perturbation of DNA,
and not RNA or other cellular macromolecules,
initiates carcinogenesis (see below). Significantly,
ethylated bases observed in tRNA of ethionine-
treated animals have their methylated analogues in
normal tRNA (Craddock et al., 1968; Dunn, 1959,
1963; Smith & Dunn, 1959), suggesting that tRNA
methylases operate with a relaxed specificity for
alkyl group donor and can utilize either SAE or
SAM. On the other hand, since 5-ethylcytosine is
not found in DNA from ethionine-treated animals
(Craddock, 1971), DNA methylases apparently
possess a strict requirement for SAM. Because
DNA methylases cannot utilize SAE, methylation
of specific cytosines would be blocked in its
presence. As this block continues throughout
subsequent replications in the presence of
concentrations of SAE capable of inhibiting DNA
transmethylation reactions, the degree of cytosine
hypomethylation would increase. The consequence
would be an impaired gene regulation, leading to
incomplete and abnormal differentiation. Since the
replicative index of liver is very low, the model
suggests that ethionine would be carcinogenic only
at high concentration capable of inhibiting DNA
methylase over extended periods. Such are the
requirements for the induction of hepatic tumours
by ethionine (Farber, 1963).
Other compounds that interfere with DNA
methylation might also be expected to lead to
changes in cellular differentiation and trans-
formation. Whereas ethionine may inhibit DNA
methylation by reducing cellular pools of SAM, 5-
azacytidine (5-AzaCyt), an analogue of cytidine in
which carbon 5 has been replaced by nitrogen,
profoundly impairs methylation by masking the
methyl acceptor site. Jones & Taylor (1980) have
shown that 5-AzaCyt induces marked changes in
differentiation of cultured mouse embryo cells. In
testing other analogues substituted at the 5-position
and elsewhere, these authors determined that
changes in gene expression induced by such
compounds correlated with their ability to inhibit
DNA methylation.
Since certain DNA methylases ("maintenance
methylases") may require hemimethylated double-
stranded DNA as substrate (Pollack et al., 1980;
Bird, 1978), replications subsequent to a single
treatment with 5-AzaCyt could produce fully
unmethylated sequences, resulting in the permanent
loss of 5-mC signal recognition sites for
maintenance methylase activity. Constantinides et al.
(1978) do, in fact, report that changes in the
differentiated state induced in cell cultures by
5-AzaCyt occur by 8 to 11 cell divisions after
treatment. At that time, the initial 5% substitution
of 5-AzaCyt for cytosine bases in DNA have been
reduced to a vanishingly small number. The 65%
inhibition of DNA methylation observed by these
authors in 5-AzaCyt-treated cultures would imply
the erasing of previously established patterns of
methylation by loss of a site of post-transcriptional
modification. These observations suggest that
5-AzaCyt might be carcinogenic in tissues capable
of incorporating it into their DNA. Likely targets
might include rapidly replicating tissues such as the
liver after partial hepatectomy, and the gastro-
intestinal tract. This suggestion may have some
clinical relevance in view of the use of 5-AzaCyt as
a chemotherapeutic agent (Armitage & Burns, 1977;
Saiki et al., 1978; Vogler et al., 1976; Von Hoff et
al., 1976).
5-AzaCyt is mutagenic in E. coli, Salmonella
Typhimurium, and V79 Chinese hamster cells (Fucik
et al., 1965; Marquardt & Marquardt, 1977), and
limited evidence is available for its carcinogenic
potential (Stoner et al., 1973; NCI, 1978; IARC,
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Impaired methylation and hereditary tyrosinemia
Methionine-deficient diets, which lead to decreased
hepatic SAM pools, greatly potentiate the effects of
a variety of liver carcinogens (Poirier et al., 1977;
Rogers & Newberne, 1980). These experimental
results may have their natural counterpart in man
in the disease known as hereditary tyrosinemia
(HT). HT is a rare inborn metabolic disease
characterized by hepatocellular and renal tubular
dysfunction. Affected children usually die before
the end of their second year, with hepatocarcinoma
as the cause of death in most instances (Weinberg
et al., 1976). Notably, these individuals are unable
to utilize methionine. Belanger et al. (1976) have
shown that free hepatic methionine levels are
severalfold higher than in control and are paralleled
in the blood by high a-fetoprotein (AFP) levels, a
protein of unknown function usually found in
significant amounts only in foetal liver, foetal
serum and in many tumours. The high incidence of
hepatoma in HT and the increased AFP-production
with tumour growth suggest that the cells
producing AFP are in a premalignant condition.
Since AFP production correlates with the degree of
methionine metabolism block in these patients,
these authors have suggested that the normal
ontogenic repression of AFP might depend on a
methionine-related metabolic event, for example,
the activation of a differentiation control
mechanism working through a transmethylase
pathway. This suggestion is based in part upon an
observation by Gaull et al. (1970) that levels of
methionine adenosyltransferase (MAT) are greatly
decreased in hypermethionemic HT children. More
recently Liau et al. (1979) reported that livers of
children who died of HT showed abnormal MAT
isozyme patterns. Such defects contrasted with
normal development in which AFP repression and
MAT expression are inversely related (Belanger et
al., 1976). Since hepatocytes of hypermethionemic
HT patients have a depressed MAT activity,
decreased SAM levels can be inferred and have
indeed been reported (Forrester & Hancock, 1978).
One can expect that reduced SAM pools would
lead to hypomethylation of hepatic DNA in these
children, just as it does in the animal models
discussed above. We suggest that such hypomethyl-
ation of DNA may account for both the altered
enzyme composition and the frequency of
hepatocellular carcinoma observed in HT.
Effects ofpyridoxine deficiency
In possibly related studies, Foy et al. (1974) found
that diets deficient in pyridoxine, a required
cofactor for transmethylation reactions, induced
multiple atypical hyperplastic nodules in the livers
of treated baboons and the appearance of AFP in
serum. Such changes following pyridoxine
deficiency were more severe than those observed
following administration of the potent
hepatocarcinogen, aflatoxin B1. These workers
further noted that histological changes in the livers
of these baboons merely deprived of this specific
dietary substance were the same as those observed
in rats fed the hepatocarcinogen dimethylamino-
azobenzene (DAB). Since both pyridoxine
deficiency, by cofactor depletion, and DAB,
possibly by mutagenic alteration of 5-mC sites,
might induce a hypomethylated state in DNA, a
unifying hypothesis to explain their similar effects
can begin to be perceived. Because agents as diverse
as ultraviolet radiation, ethionine, dimethylnitro-
samine, dimethylhydrazine and acetylaminofluorene
all have been shown to induce hypomethylation in
their respective target tissues (Lapeyre & Becker,
1979; Cox and Irving, 1977; Kasten et al., 1982;
Nyce & Magee, unpublished observations), the
hypothesis becomes potentially testable.
Effects ofcholine deficiency
A speculative but nonetheless cogent connection
between possible hypomethylation and cancer is the
long known and marked effects of choline and
methionine deficiency in enhancing the incidence of
liver cancer in rats fed such hepatocarcinogens as
aflatoxin B1, diethylnitrosamine, and N-2-
fluorenylacetamide (Rogers & Newberne, 1980).
A role for methionine follows directly from its role
in transmethylation after conversion to S-
adenosylmethionine. However, a molecular
mechanism for a protective effect of choline on
hepatocarcinogenesis has not been reported.
It has been known for many years that choline is
oxidized by liver mitochondria to betaine and that
betaine serves as a methyl donor to homocysteine
in the formation of methionine (Meister, 1965;
Skiba et al., 1982).
1. (CH3)3NCH2CH2OH+20->
(CH3)3NCH2COO +H20
2. (CH3)3NCOO- +HSCH2CH2CHNH2COOH
-+CH3SCH2CH2CHNH2COOH
+(CH3)2NCH2COOH
Since choline deficiency exerts a carcinogenic
action only in liver, (Rogers & Newberne, 1980) it is
noteworthy that the enzyme, betaine-homocysteine
methyltransferase, is active only in liver (Stekol,
1955; Meister, 1965). These conditions prompt the
suggestion that the integrity of liver metabolism is468 J. NYCE et al.
dependent on methionine, and that choline is
effective for this purpose in so far as it provides the
methyl group for methionine synthesis in this organ.
DNA repair, aging and viral carcinogenesis
We have discussed 06-alkylguanine as a significant
lesion in tumour development because of its ability
to eliminate methylation sites through G C-+A:T
transitions. Because we are offering our model as a
general description of the development of neoplasia,
we wish to point out that any DNA adduct leading
to the loss of methylation sites might be potentially
tumorigenic. Conversely, genetic lesions which do
not induce hypomethylation would not, according
to the model, be carcinogenic.
Pfohl-Leskowitz et al. (1981) have shown that
binding of 2-(acetylamino)-fluorene to C-8 of
guanine inhibits DNA methylation irreversibly, thus
possibly explaining the mechanism of carcinogenic
action of this compound. In terms of carcinogen-
DNA adducts leading to hypomethylation, one of
the major predictions of our model is that
alkylation of 5-mC moieties in DNA may be the
most potently tumorigenic of all. Preliminary
evidence from our laboratory suggests the
formation of such lesions in vitro. Alkylation or
other carcinogen-induced modification of 5-mC
would significantly alter the character of the major
groove of DNA. Any signal properties provided by
5-mC might consequently become impaired.
Changes in the base pairing properties of 5-mC
alkylation products are also possible. For example,
alkylation at either 02 or N4 might give 5-mC a
base pairing bond configuration more characteristic
of thymine than cytosine. In replicating tissues, the
resulting alkyl 5-mC:G-.T:A transitions would
create the same disturbance in gene expression and
subsequent development of neoplasia postulated for
06-alkylguanine-induced G:C-.A:T transitions.
Since 5-mC is not inserted into DNA de novo but
occurs only by postreplicational methylation of
cytosine, even the prompt repair of 5-mC alkylation
products, if it occurs by a patch repair mechanism,
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may leave DNA in a hypomethylated state. With
such repair, inserted cytosines must be remethylated
prior to replication in order to prevent the heritable
loss of hemimethylated substrate for maintenance
methylase activity. One might guess, therefore, that
a transmethylase similar to that observed for 06_
alkylguanine might be operative (discussed below).
Repair effected by such a transmethylase would
leave 5-mC in place, and hence be much less likely
to upset the pattern of gene expression.
The model also offers an explanation for the
observed increased susceptibility of older animals,
including man, to spontaneous or chemically
induced tumours (Ebbesen, 1974, 1977; Magee,
1978). Kudryashova & Vanyushin (1976a,b) and
Vanyushin et al. (1980) have found that the DNA
of old animals is hypomethylated when compared
to that of young animals of the same sex and
strain. That this may be due to spontaneous
deamination of 5-mC to thymine is suggested by
work with both prokaryotic and eukaryotic systems.
Coulondre et al. (1978) have observed - that
spontaneous base substitution hotspots within
the lac I gene of E. coli are due to deamination of
5-mC. Bird (1980) has discussed the relative scarcity
of GC dinucleotides in vertebrate DNA along
similar lines, providing evidence that 5-mC tends to
mutate abnormally frequently to thymine. Although
the deamination of adenosine to inosine and
cytosine to uracil are also known to occur, the
removal of these products can be effectively
accomplished by the base excision repair system
(Lindahl, 1979). However, since the deamination of
5-mC yields thymine, the excision of this product
seems unlikely.
We suggest that spontaneous deamination of
5-mC to thymine, with the subsequent formation of
5-mC:G-+T:A transitions (Figure 2), may explain
the increased susceptibility to carcinogenesis that
occurs with increasing age, since such transitions
would accumulate over the lifetime of the animal.
If relevant controlling regions become completely
unmethylated as a result of such spontaneous
deamination reactions, then the affected cell might
Figure 2 Diagrammatic representation of gene activation by multiple 5mC:G-*T:A transition mutations.
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give rise to a "spontaneous" neoplasm. But even
the partial methyl-depletion of multiply methylated
controlling regions would increase the probability
that a carcinogenic insult to DNA would result in a
neoplastic effect. Simply stated, if "old" DNA is
undermethylated, fewer hypomethylating mutations
would be required to put it over the regulatory
threshold.
A recent statistical analysis of tumours occuring
in patients over 50 years old suggested that the
tumours studied, and their numbers, could be
related to a decrease in the integrity of the genome
(Dix et al., 1980). The spontaneous deamination of
5-mC and the subsequent generation and collection
of 5-mCGG-.T:A transitions may, according to our
model, contribute to the age-associated decline in
genome integrity suggested by these authors. If
true, then chemical carcinogens might be said to
exert their tumorigenic effects by mimicking a
natural phenomenon.
Since the induction of tumours by viruses is well
established, we wish to point out that variable
patterns of DNA methylation in virus-transformed
cells have been reported (Rubery & Newton, 1973;
Browne & Burdon, 1977; Greene et al., 1975;
DeWichter et al., 1971; Berneman et al., 1978).
Groudine et al. (1981) recently showed that the 5-
AzaCyt-induced hypomethylation of an endogenous
retroviral gene of chick embryo erythrocytes results
in the activation of this genome as judged by
DNAse sensitivity, transcription and synthesis of
viral proteins. Other observations relating DNA
hypomethylation to viral carcinogenesis have been
made. For example, proviral mouse mammary
tumour virus (MMTV) DNA sequences acquired
from milk in animals at high risk for breast cancer
are undermethylated compared to endogenous
MMTV sequences that are associated with a much
reduced risk (Breznik & Cohen, 1982). Since an
inverse relationship has been demonstrated between
proviral methylation and transcriptional activity,
derepression of endogenous proviruses through
demethylation of these sequences may represent the
mechanism of MMTV-induced tumorigenesis
(Breznik & Cohen, 1982). Analysis of the
methylation pattern of the viral thymidine kinase
(TK) gene in Herpes simplex virus (HSV)-
transformed mouse cells showed that when the gene
was being actively transcribed it was unmethylated,
when inactive it was methylated, and when induced
to activity by 5-AzaCyt it was again unmethylated.
This finding was extended by Waechter & Baserga
(1982) who found that when the cloned gene for
HSV-TK was methylated with Eco RI methylase
and microinjected into the nucleus of TK"-) cells,
methylation at particular sites markedly reduced or
abolished the expression of the gene. These authors
pointed out the possibility that different genes
might respond differently to methylation, since
similar Eco RI methylation of the gene coding for
Simian virus 40 T antigen had no effect upon its
expression after microinjection. A causative
relationship between DNA methylation and
decreased gene expression in Herpes simplex TK
genes was also observed by Christy & Scangos
(1982). Diala & Hoffman (1982) observed hypo-
methylation of HeLa cell DNA and the absence of
5-mC in SV40 and adenovirus (Type 2) DNA.
Desrosiers et al. (1979) observed that viral DNA in
cells of Herpesvirus saimiri transformed non-
producing lymphoid cell lines contains DNA
methylated at cytosine positions which are
unmethylated in virion DNA and in DNA of
lymphoid cell lines that produce virus. In other
studies an inverse correlation was observed between
the levels of methylation of integrated adenovirus
(Type 12) DNA sequences and viral gene expression
in transformed hamster cells (Sutter & Doerfler,
1980). These results suggest that hypomethylation
of DNA may provide a common transforming
mechanism shared by chemical carciidogens and
oncogenic viruses.
Genetic vs. epigenetic considerations
A purely epigenetic model of carcinogenesis, also
concerned with the effects of hypomethylation upon
cell populations, has been put forward (Holliday,
1979). This model proposes that damage to DNA
results in the potentially reversible loss of methyl
groups as a function of repair processes. This
would occur either as a result of repair before
DNA synthesis, and before appropriate methylases
have remethylated newly inserted cytosines, or as a
result of recombination following damage to DNA.
There are, however, observations which detract
from this otherwise attractive hypothesis. Thus,
while the persistence of 06-alkylguanine correlates
well with the tumour susceptibility of various
tissues and that of 7-alkylguanine does not, these
lesions would be predicted by the purely epigenetic
model to be equally tumorigenic if sequences
containing them were excised, then repaired, but
not remethylated prior to DNA replication. Yet
methyl methanesulfonate (MMS), which produces
extensive methylation at the N7 position of guanine
and only insignificant amounts of the 06-alkylated
product, is not hepatocarcinogenic in the rat even
when administered in the wave of DNA replication
which follows partial hepatectomy (Craddock,
1975). Furthermore, evidence has accumulated
which suggests that, while 7-alkylguanine is
removed from DNA by a base excision process
presumably susceptible to repair-associated DNA
hypomethylation, O6-alkylguanine is repaired in a
transmethylase reaction where base integrity470 J. NYCE et al.
remains intact (Olson & Lindahl, 1980; Pegg et al.,
1982; Waldstein et al., 1982; Renard et al., 1981;
Regan & Setlow, 1974). Thus the repair mechanism
for 06-alkylguanine does not proceed by an excision
system that would deplete 5-mC. Sequences
containing methylated cytosines in the vicinity of
such lesions remain intact. Since there are no gaps
to fill, there is no reason to expect that 06_
alkylguanine repair would lead to hypomethylation.
The repair-associated hypomethylation model
therefore suffers from the flaw that it predicts that
7-alkylguanine, but not 06-alkylguanine, is a
critical oncogenic lesion, when exactly the opposite
seems to be true. It would appear, then, that
fixation of 06-alkylguanine lesions via G.C-+A:T
transition mutations is a more likely mechanism of
carcinogenesis, at least for alkylating carcinogens,
than that postulated in the purely epigenetic model.
The molecular basis underlying the relationship
between mutagenesis and carcinogenesis has
become increasingly substantial (see Magee, 1977b).
Thus, most chemical carcinogens are also mutagens
(Ames & McCann, 1976; McCann & Ames, 1977);
tumours appear to be clonal in origin, suggesting
the occurrence within a single cell of a permanent
molecular alteration (Gould et al., 1978); cells that
are more sensitive to mutagenic lesions are also
more sensitive to malignant transformation (Cleaver
& Bootsma, 1975; Mortelman et al., 1976; Takebe
et al., 1977); mutagenic metabolites produced by
metabolic activation within tumour-susceptible
organs have been identified as ultimate carcinogens
(Felton & Nebert, 1975); and the direct
perturbation of DNA has been shown to be
sufficient to initiate neoplastic transformation
(Barrett et al., 1978). Yet Cairns (1981) has
convincingly championed the argument that many
cancers may be caused by non-mutational
mechanisms (e.g., cancers arising in tissues next to
implanted sheets of plastic, or induced by
implantation of ovary or embryo cells into sites
where constraints upon their cellular multiplication
are removed). He has concluded that there is no
obvious connection between the many ways that
tumours can be induced. One strength of the hypo-
methylation model is that it provides such a
common link between diverse carcinogenic
stimulae. Another strength is that it provides a
basis for believing the difference between
mutational and epigenetic mechanisms may be
more apparent than real, with both mechanisms
sharing considerable overlap. As an example, one
may consider the loss of hemimethylated sites for
DNA methylase that would occur if 5-mC were to
be modified by an alkylating carcinogen, repaired
but not remethylated before the next round of
DNA synthesis. Similarly, interference with DNA
methylase induced by ethionine could lead to
permanent alteration in the pattern of methylation
of the genetic material. Are such changes in the
expressible nature of the involved DNA to be
considered mutational or not? They do, after all,
disrupt the clonal inheritance of the genomic
methylation pattern (Riggs, 1975; Holliday & Pugh,
1975). Yet, in the case of ethionine-induced hypo-
methylation, if a sequence-specific methylase
capable of acting upon completely unmethylated
sites could be induced, the methylation pattern
could theoretically be fully restored. In this
scenario, the boundaries between epigenetic and
mutational mechanisms of carcinogenesis become
obscure.
We might point out here that short-term bacterial
mutagenesis assays may produce some false
negative results when testing the relationship
between carcinogenesis and mutagenesis because of
differences in the methylated bases occurring in
prokaryotes and eukaryotes, and their different
functions. For example, a compound like ethionine
which is not overtly genotoxic does not test
positively in a Salmonella typhimurium revertant
assay (McCann et al., 1975), yet is clearly
carcinogenic in eukaryotes. The number of other
substances tested which are either mutagens or
carcinogens but not both offer perhaps one of the
most intriguing avenues for research into the basic
mechanism of tumorigenesis.
Cellular oncogenes
While the model presented here implies widespread
changes in gene expression as a result of
chemically-induced hypomethylation of DNA, it is
entirely possible that only one or a few of the
newly activated genes are responsible for
transformation. Much of the recent work on
cellular oncogenes suggests that this may be the
case (for a review see Weinberg, 1982). From our
point of view, the cellular oncogene (or oncogenes)
would be one or a few of many genes activated
during carcinogen-induced hypomethylation.
Certain retro-viruses incorporate into their DNA a
cellular gene which is thus released from host
control (Weinberg, 1981). This collapse of host
regulatory function for the oncogene might
involve actual demethylation of the host sequence
incorporated into the virion (Breznik & Cogen,
1982) or physical separation of the oncogene from
the methylated host DNA sequence responsible for
its repression. Integration of the avian leukosis viral
genome next to a specific cellular oncogene has
been shown to occur, and to transcriptionally
activate the gene (Hayward et al., 1981).
Possible candidates for genes with oncogenic
potential may include those genes for 5-mC
demethylase or 5-mC deaminase. While the former5-mC DEPLETION DURING TUMOUR DEVELOPMENT 471
activity has been reported in murine erythro-
leukemic cells (Gjerset & Martin, 1982), no
evidence exists for the latter, although its function
during early development remains an attractive
theoretical possibility (Holliday & Pugh, 1975).
Since the levels of hypomethylation following
treatment with alkylating agent appear to be larger
than would be expected based upon the number
of pro-mutagenic 06-alkylguanine lesions induced,
it is possible that low level hypomethylation
occasionally releases the gene for a putative 5-mC
demethylase from repression, initiating a cascade of
newly expressed genes which release the cell from
growth control.
Tumour promotion
An early and profound effect of tumour promoters
is the stimulation of mitotic activity and cell
proliferation (Diamond et al., 1980). All that may
be required of a promoter is that it induce a
condition of chronic regenerative hyperplasia in the
target tissue (Argyris, 1981). Since replication is
required in order for hypomethylation-inducing
lesions to become fixed in DNA, promoters may
exert their effect primarily by increasing the
rapidity of cell turnover. As can be seen in Figure
1, an initiating event such as the formation of
06-alkylguanine orspontaneousdeaminationof5-mC
to thymine will not be expressed until successive
DNA replications lead to hypomethylation.
This would be consistent with the long latent
periods observed between initiation and
administration of promoter that are possible in
some experimental systems. Once the genetic
damage has been permanently fixed into the DNA
in the form of lost sites of enzymatic methylation,
many months or even years may elapse before that
cell is induced to undergo proliferation, or does so
spontaneously. When proliferation is resumed,
however, the undermethylated genome may allow
the expression of previously repressed genes, some
of which may release the cell from growth control.
We conclude our discussion by drawing attention
to Table I. It is remarkable that in every system in
which DNA hypomethylation is encountered,
neoplasia follows. It is, of course, possible that this
accumulation of circumstantial evidence may be
misleading, and it is always difficult to separate
cause from effect, especially in a subject as complex
as neoplastic transformation. Nevertheless, the
correlation between DNA hypomethylation and
neoplastic transformation is intriguing and certainly
deserving of serious investigation.
Table I Systems in which hypomethylation of DNA may initiate the transformed state
AGENT OR CONDITION AFFECTING
DNA METHYLATION AFFECTED SYSTEM
MECHANISM OF INDUCTION OF
DNA HYPOMETHYLATION
Chemical alkylation (e.g.,
by N-nitroso-or related
compounds)
Other carcinogen-induced
modifications (e.g. Benzo
(a) Pyrene, aflatoxin Bi,
AAF, DAB)
Ethionine, hereditary tyrosinemia,
choline/methionine deficiency
Pyridoxine deficiency
5-azacytidine
Aging
Viruses
DNA
DNA
DNA methylase system
DNA methylase system
DNA
DNA
Host DNA, DNA
methylase system
G C - A:T transition
mutations which delete
present or potential sites
of enzymatic DNA methylation
E.g., AAF insertion-
denaturation of DNA and
subsequent irreversible
inhibition of DNA methylase
(Pfohl-Leskowicz et al, 1981)
Reduction of SAM pool size
and subsequent inhibition of
DNA methylase
Cofactor depletion and
subsequent inhibition of
DNA methylase
Loss of methylatable cytosine
residues in CpG sequences
5mC.G - T:A transition
mutations due to spontaneous
deamination
a) differential methylation of
host vs viral DNA by virus
associatd DNA mathylase?
b) insertion mutation?472 J. NYCE et al.
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